Nevro Corp. (NVRO) |
|
23.47 -4.05 (-14.72%)
|
06-06 15:59 |
|
Open: |
23.57 |
Pre. Close: |
27.52 |
|
High:
|
24.13 |
Low:
|
22.12 |
|
Volume:
|
1,515,195 |
Market Cap:
|
841(M) |
|
|
|
Technical analysis |
as of: 2023-06-06 3:51:03 PM |
|
Short-term rate:
|
  |
| Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected. |
|
Mid-term rate:
|
|
| Target: |
Six months: 30.72 One year: 33.74 |
| Support: |
Support1: 22.12 Support2: 18.4 |
| Resistance: |
Resistance1: 26.3 Resistance2: 28.88 |
| Pivot: |
26.97 |
| Moving Average: |
MA(5): 26.9 MA(20): 27.15
MA(100): 32.77 MA(250): 39.41 |
| MACD: |
MACD(12,26): -1.1 Signal(9): -1.2  |
| Stochastic oscillator: |
%K(14,3): 53.5 %D(3): 59.6 |
| RSI: |
RSI(14): 31.2 |
| 52-week: |
High: 53.34 Low: 22.12 |
| Average Vol(K): |
3-Month: 539 (K) 10-Days: 492 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ NVRO ] has closed below the lower bollinger band by 29.8%. Although price has broken the lower band and a downside breakout is possible; the most likely direction for [ NVRO ] is to continue within current trading range. Bollinger Bands are 37.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
28.4 - 28.54 |
28.54 - 28.65 |
|
Low:
|
26.94 - 27.13 |
27.13 - 27.28 |
|
Close:
|
27.26 - 27.54 |
27.54 - 27.77 |
|
Company Description |
|
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California. |
Headline News |
Tue, 06 Jun 2023
Coinbase, Blue Bird, Tingo Group And Other Big Stocks Moving ... - Investing.com UK
Tue, 06 Jun 2023
M&T Bank Corp Lowers Position in Nevro Corp. (NYSE:NVRO) - MarketBeat
Mon, 05 Jun 2023
2023-06-05 | NYSE:NVRO | Press Release | Nevro Corp. - Stockhouse Publishing
Sat, 03 Jun 2023
Nevro (NYSE:NVRO) adds US$65m to market cap in the past 7 days, though investors from three years ago are still down 78% - Simply Wall St
Thu, 01 Jun 2023
Thursday’s Top Analyst Upgrades and Downgrades: Chevron, Coty, Twilio, Viking Therapeutics, Xylem and More - 24/7 Wall St.
Mon, 22 May 2023
Russell Investments Group Ltd. Has $2.02 Million Stock Position in ... - MarketBeat
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NYSE |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. |
36 (M) |
| Shares Float |
35 (M) |
|
% Held by Insiders
|
2.2 (%) |
|
% Held by Institutions
|
111.8 (%) |
|
Shares Short
|
1,440 (K) |
|
Shares Short P.Month
|
1,810 (K) |
Stock Financials |
|
EPS
|
0.07 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
8.43 |
|
Profit Margin (%)
|
0.5 |
|
Operating Margin (%)
|
-24.7 |
|
Return on Assets (ttm)
|
-11.6 |
|
Return on Equity (ttm)
|
0.8 |
|
Qtrly Rev. Growth
|
9.6 |
|
Gross Profit (p.s.)
|
7.71 |
|
Sales Per Share
|
11.58 |
|
EBITDA (p.s.)
|
-2.69 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
24 (M) |
|
Levered Free Cash Flow
|
-31 (M) |
Stock Valuations |
|
PE Ratio
|
296.62 |
|
PEG Ratio
|
-0.5 |
|
Price to Book value
|
2.81 |
|
Price to Sales
|
2.04 |
|
Price to Cash Flow
|
35.74 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
